Progression from suspected to definite systemic sclerosis and the role of anti-topoisomerase I antibodies.
Sophie I E LiemSam NeppelenbroekCynthia M FehresBrigitte A WeversRené E M ToesCornelia F AllaartThomas Wj HuizingaHans Ulrich SchererJeska K De Vries-BouwstraPublished in: RMD open (2023)
Although a role of ATA in disease progression is suggested, more studies on the ATA response in suspected very early SSc are warranted.